{
  "url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005/schedule-3/paragraph-4",
  "json_url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005/schedule-3/paragraph-4.json",
  "legislation": "uksi/2005/2754",
  "legislation_title": "The Medicines (Advisory Bodies) (No. 2) Regulations 2005",
  "legislation_url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005",
  "path": "schedule/3/paragraph/4",
  "kind": "paragraph",
  "number": "4",
  "heading": null,
  "text": "(1) Regulation 31 (suspension or termination of clinical trial) shall be amended as follows.\n(2) In paragraph (7), omit “or, if for the time being there is no such committee, the Medicines Commission”.\n(3) In paragraph (8), omit “or, as the case may be, the Medicines Commission”.\n(4) In paragraph (9), omit “or the Medicines Commission”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2005/2754/schedule/3/paragraph/4",
    "retrieved_at": "2026-10-29T04:49:26.804880+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}